A study published in Nature Neuroscience suggests that the cannabinoid receptor type 1 (CB1) could play a role in regulating stress responses by maintaining vascular integrity in the brain. The ...
The drug, known as VIP36, targets the body’s cannabinoid receptor type 1 (CB1). It was found to be effective in three different animal models for pain and does not appear to cause the harmful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback